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Frozen osteoarticular grafts treated with liquid nitrogen are utilized for joint 
reconstruction after tumor resection, but the joints may subsequently develop 
osteoarthritic changes. To preserve articular cartilage from cryoinjury, we modified a 
vitrification method utilized for embryo cryopreservation and demonstrated in vitro that 
our vitrification protocol was effective for protecting cartilage from cryoinjury. In this 
study, we investigated in vivo whether this vitrification method could protect against 
osteoarthritic changes in articular cartilage. Osteochondral plugs were obtained from the 
distal femur of rabbits. These grafts were divided into 3 groups: Fresh group (F-group), 
non-vitrification group (N-group), and vitrification group (V-group). After treatment, 
the plugs were re-implanted as autografts. Histological findings, chondrocyte viability, 
and ultrastructural examinations were examined 6, 12, and 24 weeks after implantation. 
Histological findings of chondrocytes for the V- group showed no significant difference 
from those of the F-group at any time point except at 24 weeks postimplantation at the 
non-weight bearing site (p<0.05).Viability of chondrocyte showed no significant 
difference from those of the F-group except at 12 weeks postimplantation at the bearing 
site (p<0.05). In contrast, viable cells disappeared from the N-group and histology and 
viability significantly differed between the N-group and the V-group. Transmission 
electron microscopy demonstrated preservation of chondrocyte structure in the V-group 
and the F-group, but chondrocytes of the N-group were abnormally electron dense . Our 
vitrification method was effective in protecting chondrocytes from cryoinjury that might 
lead to cartilage degeneration. Reconstructing joints with osteoarticular grafts 
containing living cartilage may help to avert osteoarthritic changes. Our vitrification 
method could prove useful for reconstruction with frozen tumor-containing autografts 
and for long-term storage of living cartilage for allografts.  
【Introduction】 
Improvements in survival rates associated with the advent of multidisciplinary 
treatments for sarcomas have necessitated the development of functional and durable 
methods of joint reconstruction after tumor resection. Massive prostheses and allografts 
are the two standard approaches to managing bone defects after tumor excision. 
Reconstructions with massive prostheses provide immediate postoperative stability and 
an early return to daily activities, but recipients are at risk for late complications such as 
aseptic loosening, mechanical failure and, especially in young patients, bone 
loss[2,5,26]. Reconstructions with allografts are being performed in some countries, but 
the procedure is not acceptable in certain Asian countries, particularly in Japan, because 
of socio-religious reasons. Therefore, in order to offer patients another alternative, 
various devitalizing methods, including irradiation[32], autoclaving[12,31], and 
pasteurization[16] have been investigated to enable re-use of  resected 
tumor-containing bone in joint reconstruction.  
We have developed a new reconstruction method using frozen autografts in which the 
resected tumor-containing bone is immersed into liquid nitrogen (LN2) for 20 min to kill 
tumor cells, after which the tissue is re-grafted at the same location[33]. An in vitro 
study verified that our liquid nitrogen treatment method totally devitalized sarcoma 
tissues such as osteosarcoma[36]. We have performed reconstructions with frozen 
autografts since 1999, and no recurrences of sarcomas from the grafted bone have 
occurred. The advantages of our freezing method include the following: simplicity, 
osteoinduction, osteoconduction, a perfect fit, sufficient biomechanical strength, and 
induced cryoimmunological anti-tumor effects[20,36]. Unfortunately, joints that have 
been reconstructed with frozen autografts may later develop osteoarthritic changes, a 
complication that also can occur following other biological reconstructions[16,37].  
We thus initiated research to clarify the cause of joint degeneration in reconstructions 
using frozen autografts and to identify methods for preventing this complication. Our 
investigations found that frozen grafts were incorporated into the host bone and that 
excellent remodeling occurred in frozen bone. On the other hand, cartilage degeneration 
progressed in the frozen bone grafts, although the structures of the other joint 
components were well-preserved[7]. Previous study have reported cartilage degeneraton 
caused by cryoinjury, which caused ice crystal formation [34].  
To preserve articular cartilage from cryoinjury, we sought to develop a method to 
protect cartilage selectively from cryoinjury, which is one of the causes of the 
subsequent osteoarthritic changes. Some investigators have examined cryoprotectants 
and cryopreservation protocols in an effort to enable preservation of viable cells during 
freezing-thawing[1,24] . However, preserving the viability of structured tissues and 
organs is difficult using conventional approaches because insufficient amounts of 
cryoprotectant are not able to penetrate cells deep in the matrix to prevent 
cryoinjury[8,21]. Recently, a vitrification method was developed in the field of assisted 
reproductive technology for cryopreservation of oocytes and embryos[13,22,29]. 
Vitrification, which is promoted by a high concentration of cryoprotectants during 
cooling, results in a high percentage of cells retaining viability after thawing. We have 
modified a vitrification method utilized oocyte cryopreservation and demonstrated in 
vitro that our vitrification protocol was effective for protecting cartilage from 
cryoinjury[7]. Recent investigations on vitrification of articular cartilage have 
demonstrated protection of chondrocytes from cryoinjury in vitro [6,28,35]. One study 
with vitrification in vivo demonstrated protection of cartilage from cryoinjury 
histologically[27]. However, demonstration of in vivo function of vitrified cartilage as 
an autograft has yet to be accomplished. In vivo function and recovery of viable 
chondrocytes will allow long term maintenance of the matrix [6]. 
The objective of this study was to examine whether our vitrification method can 
protect against osteoarthritic changes of articular cartilage and preserve function of 
chondrocytes after liquid nitrogen treatment in vivo in a rabbit model and to compare 
the performance of fresh control and frozen cartilage.  
 
【Materials and Methods】 
 Adult female Japanese White rabbits, weighing 2.5-3.5 kg, were used in this study. A 
total of 45 rabbits (5 rabbits in each of subgroups) were randomly allotted to 3 groups. 
Animals were anesthetized with an intramuscular injection of ketamine hydrochloride 
(50 mg/kg body weight; Sankyo, Tokyo, Japan) and intravenous injection of 
pentobarbital sodium (50 mg/kg body weight; Dainippon Pharmaceutical, Tokyo, 
Japan). The left hind limbs were used for surgical treatment while the right hind limbs 
were left intact. 
Osteochondral plugs (2.7 mm diameter, 0.1 - 0.4 mm full-thickness articular cartilage 
on a 4 - 5 mm bone base) of anesthetized rabbits were obtained from the weight bearing 
site of the medial condyle of the femur and the non weight bearing site of the patellar 
groove of the femur using mosaicplasty (Smith & Nephew, Inc. Andover, MA) under 
sterile conditions. The plugs were transferred into phosphate buffered saline (PBS; 
Invitrogen, Carlsbad, CA, USA) and stored until use in the experiments. 
At the onset of the experiment, the plugs were divided randomly into 3 groups:  
・Fresh group (F-group) - control group, using unfrozen, fresh cartilage plugs; 
・Non-vitrification group (N-group) - direct immersion of plugs into LN2 without any 
cryoprotectants for 20 min followed by warming to room temperature; 
・Vitrification group (V-group) – pretreatment of plugs with cryoprotectants (see 
below) prior to immersion in LN2 for 20 min followed by warming to room 
temperature.  
The plugs in each group were reimplanted into the same site in the same animal. 
Histological findings, viability of chondrocytes, and ultrastructural findings in each 
group were examined at 6 weeks, 12 weeks and 24 weeks postimplantation. 
Vitrification protocol 
Osteochondral plugs were washed in fresh PBS. After washing, the plugs were 
equilibrated in PBS supplemented with 20% ethylene glycol (Wako Pure Chemical 
Industries, Osaka, Japan) and 0.3 M sucrose (Wako Pure Chemical Industries) for 2 min. 
Next, the plugs were exposed to the vitrification solution (PBS supplemented with 40% 
ethylene glycol and 0.6 M sucrose) for 2 min and then immediately immersed into LN2 
for 20 min. At the end of the 20 min period in LN2, the plugs were warmed for 5 min in 
PBS supplemented with 1 M sucrose and subsequently immersed in PBS for 5 more 
minutes to dilute the cryoprotectants. 
Histological evaluations of osteoarthritic changes 
To examine morphological changes in the cartilage, the constituent cells and 
extracellular matrix were examined by light microscopy. Specimens were prepared as 
described above and stained with hematoxylin and eosin or safranin-O. The Mankin 
score (Table1) [17] was used to evaluate the specimens, where higher numbers 
correspond with increasing amounts of osteoarthritic changes.  
Viability assay of chondrocytes 
To examine the viability of vitrified-warmed chondrocytes, the osteochondral plugs 
were washed 3 times in PBS and counterstained with 10 μg/mL bis-benzimide (Hoechst 
33342; Sigma) and 10 μg/mL propidium iodide (Sigma) for 30 min. They were then 
washed in PBS and treated with anti-fading solution (Slow-Fade; Molecular Probes, 
Eugene, OR, USA). Thin sections (approximately 0.5 mm) were cut from the plugs and 
mounted on glass slides. Labeled chondrocytes were examined using a Keyence BZ 
9000 microscope fitted with epifluorescence illumination. Viable cells emitted a blue 
fluorescence, whereas non-viable cells emitted a red fluorescence. The numbers of live 
and dead cells were counted. The percentage of live cells was used as a measure of 
viability. All sections were counted three times and the counts were averaged in order to 
calculate the percentage of live cells. 
Ultrastructural examination 
 To examine the ultrastructure of chondrocytes in each group, the constituent cells and 
extracellular matrix were examined by transmission electron microscopy (TEM). 
Specimens were prepared as described above and fixed in 2% (v/v) glutaraldehyde in 
2% paraformaldehyde-phosphate buffer at 4, then post-fixed in 2% (v/v) osmium 
tetroxide in 0.1M phosphate buffer. These specimens were then dehydrated in ethanol, 
treated with n-butyl-glycidyl ether prior to embedding in Spurr’s epoxy resin and cut 
into 1 mm cubes. One micrometer sections were then stained with 0.1% toluidine blue 
and examined by microscopy to identify areas of interest. Sections (80 nm) of suitable 
areas were cut and stained with uranyl acetate and lead citrate prior to examination by 
electron microscopy (H-7650, Japan). Approximately five to ten chondrocytes at 
various levels through these specimens were examined in detail. 
Statistical analysis 
Histopathology and histochemistry data were performed by one-way analysis of 
variance (ANOVA) followed by a post-hoc Fisher’s protected least significant 
difference test (PLSD) using the Statview program (Abacus Concepts, Inc, Berkeley, 
CA, USA). Differences with a P < 0.05 were considered significant. 
Viability data of the chondrocytes were subjected to arcsine transformation before 
analysis of variance (ANOVA). Transformed data were tested by ANOVA followed by 
a post-hoc Fisher’s protected least significant difference test (PLSD) using the Statview 




Histological evaluations of osteoarthritic changes 
 Representative images of histological and histochemical findings for the three groups 
shown in Fig. 1. In the F group, there are some changes at all time points; the surfaces 
were irregular, and the staining intensity with the Safranin-O was reduced. The cell 
density was almost normal and in one case clonal proliferation was observed. Tidemark 
integrity was intact. In the V-group, there were changes at all time points; the cartilage 
surfaces were normal or irregular, and the Safranin-O staining intensity was reduced. 
The cell density was normal. Tidemark integrity was intact. In the N-group, specimens 
with severe osteoarthritis or absence of articular cartilage was observed at each time 
point; the surfaces were irregular, with clefts or completely disorganized, and the 
Safranin-O staining demonstrated severe reduction intensity or no staining noted. The 
explants were hypocellular. Tidemark integrity was disrupted, about 50% of crossed by 
blood vessels and about 50% of intact. Histological and histochemical findings were 
similar between the F-group and the V-group at all time points. The Mankin scores of 
the three treatment groups are shown in Table 2. According to the Mankin scores, the 
total score of the V-group was significantly lower than that of the N-group at each time 
point, but there was no significant difference between the V-group and the F-group at 
any time point except at 24 weeks postimplantation at the non-weight bearing site. 
 
Viability of chondrocytes 
In the F-group, most cells stained blue and a few cells were stained red, indicating 
that the chondrocytes in the F-group were viable. Similarly in the V-group, a lot of cells 
were stained blue (viable) and a few cells were stained red (dead). In contrast, over 80% 
of grafts in the N-group had completely lost their cartilage and 0-30% of cells were 
stained blue. Quantitative viability assessment of the three treatment groups is shown in 
Table 3. The viability of the N-group was significantly lower than those of the V-group 
and the F-group at each time point. The mean viability of the V-group was more than 
70% as well as the F-group. The difference between the F-group and V-group was not 
significant at any time point, except the viability of the V-group at the weight bearing 
site was significantly higher than that of the F-group at 12 weeks postimplantation.  
 
Ultrastructural observations 
The chondrocytes of the F-group and the V-group had sub-spherical nuclei, some 
cytoplasmic organelles and discrete plasma membrane with short cytoplasmic processes 
in each time point (Fig. 2A, B). On the other hend, few chondrocytes were detected in 
the N-group and they were abnormally electron dense (Fig. 2C). However, the matrix 
was similar in appearance to that seen in the other groups. 
 
【Discussion】 
 Our investigation found that osteochondral grafts treated with liquid nitrogen after this 
vitrification method can preserve cartilage architecture similar to fresh osteochondral 
grafts upon histological evaluation at all time points. However, osteochondral grafts 
treated with liquid nitrogen alone developed osteoarthritic changes after re-implantation.     
Studies with fresh autogeneous cartilage also demonstrated that the re-implanted 
cartilage appeared grossly normal and smooth[4,15] and the Safranin-O staining 
intensity of the implanted cartilage decreased[11],but these grafts showed some 
deterioration in the quantitative scale of cartilage degradation[18]. On the other hand, 
one study with cryopreserved autogeneous cartilage demonstrated that the re-implanted 
cartilage had fewer living chondrocytes and decreased safranin-O staining[4]. These 
osteoarthritic changes might be caused by heat necrosis during the extraction of an 
osteochondral plug or due to the blunt impaction of the cartilage during the process of 
implantation[10]. Our vitrified cartilage showed some deterioration of cells, structure, 
and Safranin-O staining without cluster formation at all time points. 
Ultrastructural observation is a traditional way to examine the effects of 
cryopreservation of articular cartilage. Preserved chondrocytes of allografts showed a 
prominent rough endoplasmic reticulum and sub-spherical nuclei upon ultrastructural 
observation [6,18,30]. On the other hand, degenerated chondrocytes had electron dense 
cytoplasm and irregular nuclei [6,14].  
Although the extent and range of cryoinjury can be judged by ultrastructural and 
histological changes, it is difficult to make quantitative evaluations. One of the most 
important factors for achieving a successful clinical outcome after transplantation is 
maintaining the viability of cartilage. Therefore, viability assessment based on physical 
and biochemical properties of cells was performed by the Hoechst33342/Propidium 
iodide assay. In our previous work, we used this assessment to show that vitrified 
cartilage cell viability was >85% compared with fresh cartilage in vitro[7]. Other in 
vitro studies with vitrification reported 51-80% cell viability[6,28]. In vivo studies with 
fresh autografts and cryopreserved allografts reported that chondrocyte viability was 
preserved for a short time[19,25]. The results of viability were comparable to in vivo 
data from a study using conventional cryopreservation protocols, which was evaluated 
by the metabolic status of articular cartilage[25].  
Our findings suggest that this vitrification protocol was effective for protecting 
cartilage from cryoinjury and could preserve cartilage architecture and maintain 
function of chondrocytes. Vitrification, a cryopreservation method using a high 
concentration of cryoprotectant, can completely eliminate damage caused by ice crystal 
formation in the cytoplasm of cells during cryopreservation[9,27,35]. Past 
cryopreserved protocols consisted of slow freezing or a 2-step freezing. Slow freezing 
methods were developed to reduce ice crystal formation and to eliminate toxic and 
osmotic damage to cells through exposure to low concentrations of cryoprotectants 
while slowly decreasing the temperature[34]. However, it is difficult to completely 
eliminate intracellular ice formation by slow freezing alone as demonstrated in a study 
investigating cryopreservation of articular cartilage, where cryoinjury caused 
intracellular ice formation within chondrons, some of which occurred within 
chondrocytes[23]. In another vitrification study, damage to chondrocytes without 
cryoprotectant agent was far more pronounced than in those with vitrification[6]. 
Several studies have examined vitrification of cartilage under protocols using the VS55 
formulation (2.2M propylene glycol, 3.1M formamide, and 3.1M Me2SO) [6,27,28]. 
However, all of the vitrification protocols for cartilage to date are complicated and 
require more than 90 minutes for the stepwise addition and removal of cryoprotectants. 
We created a new protocol for cartilage preservation by modifying a vitrification 
method used for oocyte cryopreservation where we substituted ethylene glycol as the 
cryoprotectant and added it in two sequential 2-minute steps. Since our vitrification 
protocol is very simple and does not need specialized equipment and short time, our 
protocol is able to easily preserve viable cartilage. However, further investigations are 
necessary to determine whether this vitrification method can protect human articular 
cartilage from cryoinjury because it is thicker than rabbit cartilage. A more concentrated 
vitrification formulation was required for preservation of thicker cartilage. However, a 
large decrease in chondrocyte viability was observed when a vitrification protocol 
previously studied using rabbit cartilage was used for thicker porcine cartilage[3].  
In reconstructions using frozen tumor-containing autografts, if the tumor is near the 
cartilage, we cannot use this vitrification method because it will also preserve tumor 
cells that might be present in the graft. However, if the cartilage is clearly isolated from 
the tumor and if we apply vitrification solution only to the cartilage, it may be possible 
to selectively protect the cartilage from cryoinjury. 
 In conclusion, our vitrification method appears to be effective for protecting rabbit 
cartilage from cryoinjury and preserving viable chondrocytes in osteochondral 
autografts. In addition, our vitrification method is superior to conventional 
cryopreservation as well as being very simple and easy to carry out. If human cartilage 
can be selectively protected from cryoinjury with vitrification, autologous frozen whole 
joint grafts could become an ideal approach for joint reconstruction after tumor 
resection. Moreover, vitrification might also be useful for long-term storage of living 
cartilage for allografts, tissue banking and cell banking.  
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Figure legends 
Fig.1. Histopathological and histochemistry findings from each experimental group at 
24 weeks postimplantation. Full-thickness articular cartilage sections stained with 
Hematoxylin and eosin (HE) and Safranin-O. The bars represent 100 µm and 1000 µm, 
respectively.  These sections were used to calculate Mankin scores as a measure of 
osteoarthritic changes. Implanted cartilage are between arrows. (A) (B) The Fresh group 
sections show Safranin-O staining and the Mankin score is 2, documenting that cartilage 
architecture was almost normal other than surface irregularity. (C) (D) The Vitrification 
group sections also show Safranin-O staining and the Mankin score is 1, documenting 
that cartilage architecture was almost normal other than surface irregularity. (E) (F) The 
Non-vitrification group sections were devoid of chondrocytes and showed no 
Safranin-O staining of the matricies. The Mankin score was 8.  
 
Fig.2. Ultrastructural findings from each experimental group at 24 weeks with the bar at 
the bottom representing 5µm. 
(A) Chondrocytes in the F-group had sub-spherical nuclei and some cytoplasmic 
organelles and discrete plasma membrane with short cytoplasmic processes.  
(B) Chondrocytes in the V-group also had sub-spherical nuclei and some cytoplasmic 
organelles. 




b.Surface irregularities              1
c.Pannnus and surface irregularities  2
d.Clefts to transitional zone         3
e.Clefts to radial zone               4
f.Clefts to calcified zone             5
g.Complete disorganization           6
Ⅱ. Cells 
a.Nomal 0
b.Diffuse hypercellularity            1
c.Cloning     2
d.Hypocellularity    3
Ⅲ. Safranin-O staining 
a.Normal  0
b.Slight reduction                  1
c.Moderate reduction            2
d.Severe reduction                 3
e.No dye noted                     4
Ⅳ. Tidemark integrity
a.Intact 0
b.Crossed by blood vessels         1
Table 2. Mankin scores for each experimental group in weight-bearing
sites (WB) and non-weight-bearing sites (NWB) at 6, 12, and 24 weeks
(W) post-implantation
Data were expressed as the mean ± SD.  
* Significantly different compared with F-group (P < 0.05).
** Significantly different compared with F-group and V-group (P < 0.05). 
6W 12W 24W
WB NWB WB NWB WB NWB
F-group 4.2±1.6 3.2±1.1 2.8±0.4 3.8±1.9 3.8±4.6 2.6±1.5
V-group 3.0±0.7 1.8±0.4 3.0±1.0 2.2±1.1 2.0±0.0 1.0±0.7*
N-group 11.2±3.0** 9.2±2.6** 9.6±2.4** 8.2±1.3** 13.6±0.5** 13.6±0.5**
Table 3. Viability for each experimental group in weight-bearing sites (WB) 
and non-weight-bearing sites (NWB) at 6, 12, and 24 weeks (W) post-
implantation
6W 12W 24W
WB NWB WB NWB WB NWB
F-group 88.5 (85.2, 91.8) 77.6 (72.9, 82.2) 71.4 (67.8, 74.8) 69.3 (63.7, 74.6) 88.5 (85.2, 91.8) 86.5 (82.1, 90.8)
V-group 86.5 (82.2, 90.8) 73.5 (67.7, 79.1) 81.4 (77.8, 85.0)* 70.9 (66.4, 75.2) 86.5 (82.2, 90.8) 87.5 (84.1, 90.9)
N-group 5.9 (-0.4, 12.2)** 5.2 (-0.3, 10.6)** 3.7 (-1.6, 9.0)** 0** 5.9 (-0.4, 12.2)** 0**
Data were expressed as the mean and 95% confidence limits.
* Significantly different compared with F-group (P < 0.05).
** Significantly different compared with F-group and V-group (P < 0.05).
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